Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery
INTERFORCE
1 other identifier
observational
105
1 country
1
Brief Summary
The main objective of the present study is to verify, in vivo, whether shear forces computed solely based on coronary angiography and computational fluid dynamics (CFD) techniques are associated with the biomarkers indicating the prothrombotic tendency of circulating blood in situ - distally and proximally to the coronary stenosis. The study will prospectively assess the relationship between i) the value and distribution of shear rate and shear stress (SS) estimated using three-dimensional angiography and CFD techniques, and ii) atherosclerotic plaque characteristics as assessed by optical coherence tomography (OCT), iii) functional parameters of diseased vessels assessed by vessel fractional flow reserve (vFFR), and iv) in situ platelet activation, as expressed by platelet-derived microvesicles (pMVs) and small extracellular vesicles (sEVs), platelet aggregometry and other serum prothrombotic or inflammatory biomarkers sampled within the coronary artery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2023
CompletedFirst Submitted
Initial submission to the registry
February 7, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2026
ExpectedFebruary 23, 2024
February 1, 2024
2 years
February 7, 2024
February 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between the mean shear rate and shear stress values at the lesion's site and the concentration of pMVs and sEVs sampled in the distal segment of the artery.
Baseline
Secondary Outcomes (14)
Correlation between the shear stress measurements at the site of the lesion and the concentration of inflammatory biomarkers in the distal segment of the artery
Baseline
Correlation between the shear stress measurements at the site of the lesion and the platelet reactivity parameters in the distal segment of the artery
Baseline
Correlation between the shear rate and shear stress values at the site of the lesion and the gradient (delta) concentration of the pMVs and sEVs
Baseline
Correlation between the shear rate and shear stress values at the site of the lesion and the gradient (delta) concentration of inflammatory biomarkers
Baseline
Correlation between the shear rate and shear stress values at the site of the lesion and the gradient (delta) of platelet reactivity
Baseline
- +9 more secondary outcomes
Study Arms (1)
Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging
Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging. The groups will be assessed at the time of angiography with: * OCT for evaluation of plaque morphology within the coronary stenosis * Computational fluid dynamics with vFFR and estimation of value and distribution of shear rate and shear stress * Impedance aggregometry based platelet reactivity * Single-particle high-resolution flow cytometry analysis of pMVs and sEVs as well as additional platelet activation and inflammatory biomarkers * Proteomic and metabolomic characterization - in the subset of patients Biomarker assessment will be done in the blood sampled directly from coronary artery (proximal and distal segment) arteries. Shear rate/shear stress distribution and biomarkers profile will be compared between the stenotic vessel and the non-stenotic vessel (stenoses \<30%) in the same patient.
Interventions
OCT examination for precise evaluation of plaque morphology within the coronary stenosis.
Blood sampling directly from coronary artery (proximal and distal segment) arteries
The procedure is based on non-invasive assessment of vFFR and shear stress parameters with dedicated software, deriving parameters directly from coronary angiography with the calculation based on the computational fluid dynamics
Eligibility Criteria
Patients will be enrolled presenting with chronic coronary syndrome and angiographically confirmed coronary stenosis (30% - 90%) amenable to OCT imaging (according to the operator's judgment).
You may qualify if:
- Chronic coronary syndrome
- Angiographically confirmed coronary stenosis (30% - 90%)
- Amenable to OCT imaging
You may not qualify if:
- Cardiogenic shock
- ST-segment elevation or non-ST-segment elevation myocardial infarction
- Active bleeding
- Left main coronary artery disease
- Multivessel disease
- Lesions located at a distance ≤3 mm from the ostium of the vessel
- Thrombocytopenia
- Previous coronary artery bypass grafting
- Previous coronary intervention with stent implantation or balloon angioplasty
- Previous use of novel oral anticoagulants or vitamin K antagonists
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Warsawlead
- National Science Centre, Polandcollaborator
- University College, Londoncollaborator
- Queen Mary University of Londoncollaborator
Study Sites (1)
Medical University of Warsaw
Warsaw, Masovian Voivodeship, 02-097, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Tomaniak Mariusz MD PhD Assoc. Prof.
Study Record Dates
First Submitted
February 7, 2024
First Posted
February 23, 2024
Study Start
July 21, 2023
Primary Completion
July 21, 2025
Study Completion (Estimated)
July 21, 2026
Last Updated
February 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share